miR-17 as a diagnostic biomarker regulates cell proliferation in breast cancer

References

• DeSantisCEFedewaSAGoding SauerAKramerJLSmithRAJemalABreast cancer statistics, 2015: convergence of incidence rates between black and white womenCA Cancer J Clin2016661314226513636
   PubMed Web of Science ®Google Scholar
• MancaGTardelliERubelloDSentinel lymph node biopsy in breast cancer: a technical and clinical appraisalNucl Med Commun201637657057626886421
   PubMedGoogle Scholar
• FanLGossPEStrasser-WeipplKCurrent status and future projections of breast cancer in AsiaBreast Care (Basel)201510637237826989355
   PubMed Web of Science ®Google Scholar
• RussoAAndreanoAAnghinoniEA set of indicators to monitor the adherence to the guidelines for the diagnosis and treatment of breast cancerEpidemiol Prev20143811628 Italian [with English abstract]24736958
   PubMedGoogle Scholar
• CardosoFHarbeckNFallowfieldLKyriakidesSSenkusEGroupEGWLocally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnn Oncol201223suppl 7vii11vii1922997442
   PubMed Web of Science ®Google Scholar
• WangDDuanLTuZThe glasgow prognostic score predicts response to chemotherapy in patients with metastatic breast cancerChemotherapy201661421722226905743
   PubMed Web of Science ®Google Scholar
• LuJGetzGMiskaEAMicroRNA expression profiles classify human cancersNature2005435704383483815944708
   PubMed Web of Science ®Google Scholar
• LyonsPJPoitrasJJCourteauLAStoreyKBMorinPJrIdentification of differentially regulated microRNAs in cold-hardy insectsCryo Letters2013341838923435712
   PubMedGoogle Scholar
• SchneiderMRSamborskiABauersachsSZouboulisCCDifferentially regulated microRNAs during human sebaceous lipogenesisJ Dermatol Sci2013702889323452545
   PubMedGoogle Scholar
• WinbanksCEOoiJYNguyenSSMcMullenJRBernardoBCMicroRNAs differentially regulated in cardiac and skeletal muscle in health and disease: potential drug targets?Clin Exp Pharmacol Physiol201441972773725115402
   PubMed Web of Science ®Google Scholar
• WangYChenJLinZRole of deregulated microRNAs in non-small cell lung cancer progression using fresh-frozen and formalin-fixed, paraffin-embedded samplesOncol Lett201611180180826870288
   PubMedGoogle Scholar
• VorvisCKoutsioumpaMIliopoulosDDevelopments in miRNA gene signaling pathways in pancreatic cancerFuture Oncol20161291135115026984178
   PubMed Web of Science ®Google Scholar
• Meryet-FiguiereMLambertBGauduchonPAn overview of long non-coding RNAs in ovarian cancersOncotarget2016728447194473426992233
   PubMed Web of Science ®Google Scholar
• LinCWLinPYYangPCNoncoding RNAs in tumor epithelial-to-mesenchymal transitionStem Cells Int20162016273270526989421
   PubMed Web of Science ®Google Scholar
• KwanJYPsarianosPBruceJPYipKWLiuFFThe complexity of microRNAs in human cancerJ Radiat Res201657suppl 1i106i11126983984
   PubMed Web of Science ®Google Scholar
• Fred Henry WalterRVollbrechtCWernerRmicroRNAs are differentially regulated between MDM2-positive and negative malignant pleural mesotheliomaOncotarget2016714187131872126918730
   PubMedGoogle Scholar
• FengTXuDTuCMiR-124 inhibits cell proliferation in breast cancer through downregulation of CDK4Tumour Biol20153685987599725731732
   PubMedGoogle Scholar
• TreeceALDuncanDLTangWGastric adenocarcinoma microRNA profiles in fixed tissue and in plasma reveal cancer-associated and Epstein-Barr virus-related expression patternsLab Invest201696666167126950485
   PubMed Web of Science ®Google Scholar
• GomesBCSantosBRueffJRodriguesASMethods for studying MicroRNA expression and their targets in formalin-fixed, paraffin-embedded (FFPE) breast cancer tissuesMethods Mol Biol2016139518920526910075
   PubMedGoogle Scholar
• HanYXuGXLuHDysregulation of miRNA-21 and their potential as biomarkers for the diagnosis of cervical cancerInt J Clin Exp Pathol2015867131713926261606
   PubMed Web of Science ®Google Scholar
• WenJYeFHeXDevelopment and validation of a prognostic nomogram based on the log odds of positive lymph nodes (LODDS) for breast cancerOncotarget2016715210462105326992235
   PubMedGoogle Scholar
• FangYXuCFuYMicroRNA-17-5p induces drug resistance and invasion of ovarian carcinoma cells by targeting PTEN signalingJ Biol Res (Thessalon)2015221226500892
   PubMed Web of Science ®Google Scholar
• CohenRGreenbergENemlichYSchachterJMarkelGmiR-17 regulates melanoma cell motility by inhibiting the translation of ETV1Oncotarget2015622190061901626158900
   PubMedGoogle Scholar
• JinYYAndradeJWickstromENon-specific blocking of miR-17-5p guide strand in triple negative breast cancer cells by amplifying passenger strand activityPLoS One20151012e014257426629823
   PubMed Web of Science ®Google Scholar
• ZhouPMaLZhouJmiR-17-92 plays an oncogenic role and conveys chemo-resistance to cisplatin in human prostate cancer cellsInt J Oncol20164841737174826891588
   PubMedGoogle Scholar
• ConevNVDonevISKonsoulova-KirovaAAChervenkovTGKashlovJKIvanovKDSerum expression levels of miR-17, miR-21, and miR-92 as potential biomarkers for recurrence after adjuvant chemotherapy in colon cancer patientsBiosci Trends20159639340126781797
   PubMed Web of Science ®Google Scholar
• PalanichamyJKRaoDSmiRNA dysregulation in cancer: towards a mechanistic understandingFront Genet201455424672539
   PubMed Web of Science ®Google Scholar
• MulraneLMcGeeSFGallagherWMO’ConnorDPmiRNA dysregulation in breast cancerCancer Res201373226554656224204025
   PubMed Web of Science ®Google Scholar
• IliopoulosDPolytarchouCHatziapostolouMMicroRNAs differentially regulated by Akt isoforms control EMT and stem cell renewal in cancer cellsSci Signal2009292ra6219825827
   PubMedGoogle Scholar
• ErolesPTormoEPinedaBEspinELluchAMicroRNAs in breast cancer: one more turn in regulationCurr Drug Targets20161791083110025694121
   PubMedGoogle Scholar
• LiuHMicroRNAs in breast cancer initiation and progressionCell Mol Life Sci201269213587359922926415
   PubMedGoogle Scholar
• GongAYEischeidANXiaoJmiR-17-5p targets the p300/CBP-associated factor and modulates androgen receptor transcriptional activity in cultured prostate cancer cellsBMC Cancer20121249223095762
   PubMed Web of Science ®Google Scholar
• BahariFEmadi-BaygiMNikpourPmiR-17-92 host gene, uderexpressed in gastric cancer and its expression was negatively correlated with the metastasisIndian J Cancer2015521222526837962
   PubMedGoogle Scholar
• ZhangXKongYXuXF-box protein FBXO31 is down-regulated in gastric cancer and negatively regulated by miR-17 and miR-20aOncotarget20145156178619025115392
   PubMedGoogle Scholar
• WuQLuoGYangZmiR-17-5p promotes proliferation by targeting SOCS6 in gastric cancer cellsFEBS Lett2014588122055206224801601
   PubMed Web of Science ®Google Scholar
• ZhuJDongHZhangQZhangSCombined assays for serum carcinoembryonic antigen and microRNA-17-3p offer improved diagnostic potential for stage I/II colon cancerMol Clin Oncol2015361315131826807240
   PubMedGoogle Scholar
• KnudsenKNNielsenBSLindebjergJHansenTFHolstRSorensenFBmicroRNA-17 is the most up-regulated member of the miR-17-92 cluster during early colon cancer evolutionPLoS One20151010e014050326465597
   PubMed Web of Science ®Google Scholar
• HuSLiuLChangEBWangJYRaufmanJPButyrate inhibits pro-proliferative miR-92a by diminishing c-Myc-induced miR-17-92a cluster transcription in human colon cancer cellsMol Cancer201514118026463716
   PubMed Web of Science ®Google Scholar